Valerie G Kirk1, Heather Edgell2, Hitesh Joshi2, Evelyn Constantin3, Sherri L Katz4, Joanna E MacLean5. 1. Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada. 2. York University, Toronto, Ontario, Canada. 3. Montreal Children's Hospital, McGill University, Montreal, Quebec, Canada. 4. Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada. 5. Stollery Children's Hospital, University of Alberta, Edmonton, Alberta, Canada.
Abstract
STUDY OBJECTIVES: Adults with obesity and obstructive sleep apnea (OSA) are at risk for cardiometabolic disease, and this risk likely extends to children with both conditions. Noninvasive ventilation (NIV; including continuous and bilevel positive airway pressure) is often used to treat OSA in children with obesity. The aim of this study was to examine the impact of NIV treatment on heart rate variability (HRV), as a marker of cardiovascular risk, in children with obesity and newly diagnosed OSA. METHODS: A prospective multicenter cohort study was conducted in children with obesity prescribed NIV therapy for newly diagnosed moderate-severe OSA. Measurements of HRV were derived from polysomnography recordings at baseline and after 12 months of treatment. HRV parameters were examined by sleep stage, before and after arousal and oxygen desaturation events. HRV parameters were compared between time points using pair t tests as well as mixed model analysis. RESULTS: Twelve children had appropriate data for analysis at baseline and 12 months. Heart rate decreased by 4.5 beats/min after NIV treatment, with no change in HRV parameters. HRV parameters differed by sleep stage and showed an increase in arousal-related sympathetic-parasympathetic balance after 12 months of NIV treatment. HRV parameters did not differ before and after oxygen desaturation events. CONCLUSIONS: NIV for the treatment in children with obesity and OSA resulted in a small decrease in heart rate and an increase in arousal-related sympathetic-parasympathetic balance. These findings suggest small, potentially positive impacts of NIV on cardiovascular risk in children with concurrent obesity and OSA.
STUDY OBJECTIVES: Adults with obesity and obstructive sleep apnea (OSA) are at risk for cardiometabolic disease, and this risk likely extends to children with both conditions. Noninvasive ventilation (NIV; including continuous and bilevel positive airway pressure) is often used to treat OSA in children with obesity. The aim of this study was to examine the impact of NIV treatment on heart rate variability (HRV), as a marker of cardiovascular risk, in children with obesity and newly diagnosed OSA. METHODS: A prospective multicenter cohort study was conducted in children with obesity prescribed NIV therapy for newly diagnosed moderate-severe OSA. Measurements of HRV were derived from polysomnography recordings at baseline and after 12 months of treatment. HRV parameters were examined by sleep stage, before and after arousal and oxygen desaturation events. HRV parameters were compared between time points using pair t tests as well as mixed model analysis. RESULTS: Twelve children had appropriate data for analysis at baseline and 12 months. Heart rate decreased by 4.5 beats/min after NIV treatment, with no change in HRV parameters. HRV parameters differed by sleep stage and showed an increase in arousal-related sympathetic-parasympathetic balance after 12 months of NIV treatment. HRV parameters did not differ before and after oxygen desaturation events. CONCLUSIONS: NIV for the treatment in children with obesity and OSA resulted in a small decrease in heart rate and an increase in arousal-related sympathetic-parasympathetic balance. These findings suggest small, potentially positive impacts of NIV on cardiovascular risk in children with concurrent obesity and OSA.
Authors: Carmel Harrington; Turkka Kirjavainen; Arthur Teng; Colin E Sullivan Journal: Am J Respir Crit Care Med Date: 2002-04-15 Impact factor: 21.405
Authors: Ji Ho Choi; Jong Sook Yi; Seung Hoon Lee; Cheon Sik Kim; Tae Hoon Kim; Heung Man Lee; Bong-Jae Lee; Sang Hag Lee; Yoo-Sam Chung Journal: J Sleep Res Date: 2011-10-17 Impact factor: 3.981
Authors: Bharat Bhushan; John Maddalozzo; Stephen H Sheldon; Shannon Haymond; Karen Rychlik; George C Lales; Kathleen R Billings Journal: Int J Pediatr Otorhinolaryngol Date: 2014-03-07 Impact factor: 1.675
Authors: Andrey V Zinchuk; Sangchoon Jeon; Brian B Koo; Xiting Yan; Dawn M Bravata; Li Qin; Bernardo J Selim; Kingman P Strohl; Nancy S Redeker; John Concato; Henry K Yaggi Journal: Thorax Date: 2017-09-21 Impact factor: 9.139
Authors: Clete A Kushida; Alejandro Chediak; Richard B Berry; Lee K Brown; David Gozal; Conrad Iber; Sairam Parthasarathy; Stuart F Quan; James A Rowley Journal: J Clin Sleep Med Date: 2008-04-15 Impact factor: 4.062
Authors: Lisa M Walter; Knarik Tamanyan; Lauren C Nisbet; Margot J Davey; Gillian M Nixon; Rosemary S C Horne Journal: Int J Obes (Lond) Date: 2018-06-11 Impact factor: 5.095